title: Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
authors: Via Christi Comprehensive Epilepsy Center, University of Kansas School of Medicine-Wichita, Wichita, KS 67214-3800, USA. kliow@kumc.edu
authors: K
authors: K
authors: Liow
authors: G L
authors: GL
authors: Barkley
authors: J R
authors: JR
authors: Pollard
authors: C L
authors: CL
authors: Harden
authors: C W
authors: CW
authors: Bazil
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards*; D016568:Drugs, Generic / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards*; D004827:Epilepsy / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D005569:Formularies as Topic / Q000592:standards*; D007356:Insurance, Pharmaceutical Services / Q000592:standards; D010819:Physician's Role; D017009:Professional Autonomy; D012955:Societies, Medical / Q000592:standards; D013810:Therapeutic Equivalency; D014481:United States
chemical_list: D000927:Anticonvulsants; D016568:Drugs, Generic